Showing results (171-180 of 189) with videos related to
Sort By:
Pageof 19
The British Journal of Ophthalmology|June 1, 1983
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)A H Friedman, J Orellana, W R Freeman, et al.The American Journal of Pathology|August 6, 1999
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridizationS H Bigner, M R Matthews, B K Rasheed, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 2000
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumorsJ H Sampson, L E Crotty, S Lee, et al.Journal of the American College of Cardiology|March 27, 2001
Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in childrenF E Udink ten Cate, J M Breur, M I Cohen, et al.British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.Pediatric Cardiology|August 26, 2006
Potential additional indicators for pacemaker requirement in isolated congenital atrioventricular blockJ M P J Breur, F E A Udink ten Cate, L Kapusta, et al.Journal of Clinical Neuromuscular Disease|December 17, 2008
Clinical Studies in Non-chromosome 4-Linked Facioscapulohumeral Muscular DystrophyR W Tim, J R Gilbert, J M Stajich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor GroupW K Yung, M D Prados, R Yaya-Tur, et al.Neuro-Oncology|October 5, 2001
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomasS Gururangan, L Cokgor, J N Rich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.Pageof 19